News & Insights

Speaking Engagement

Eva Temkin to Speak at DIA Biosimilars Conference


Washington, D.C., FDA & Life Science partner Eva Temkin will speak at the DIA Biosimilars Conference on Oct. 5.  Eva will participate in a panel discussion titled “How Different Is Too Different? Differentiation Opportunities and Challenges for Biosimilars.” This panel will focus on US and EU regulatory frameworks for biosimilars and opportunities for differentiation. 

Event Details

Date: October 5, 2021